Mercer Global Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,699
| Closed | -$16K | – | 2116 |
|
|
2023
Q3 | $16K | Hold |
2,699
| – | – | ﹤0.01% | 1931 |
|
|
2023
Q2 | $19K | Sell |
2,699
-40
| -1% | -$282 | ﹤0.01% | 1894 |
|
|
2023
Q1 | $43K | Sell |
2,739
-150
| -5% | -$2.36K | ﹤0.01% | 1873 |
|
|
2022
Q4 | $58K | Buy |
2,889
+150
| +5% | +$3.01K | ﹤0.01% | 1855 |
|
|
2022
Q3 | $49K | Sell |
2,739
-5
| -0.2% | -$89 | ﹤0.01% | 1771 |
|
|
2022
Q2 | $61K | Buy |
2,744
+192
| +8% | +$4.27K | ﹤0.01% | 1761 |
|
|
2022
Q1 | $71K | Buy |
2,552
+40
| +2% | +$1.11K | ﹤0.01% | 1817 |
|
|
2021
Q4 | $114K | Buy |
2,512
+5
| +0.2% | +$227 | ﹤0.01% | 1706 |
|
|
2021
Q3 | $209K | Sell |
2,507
-2,500
| -50% | -$208K | ﹤0.01% | 1597 |
|
|
2021
Q2 | $476K | Hold |
5,007
| – | – | ﹤0.01% | 1167 |
|
|
2021
Q1 | $833K | Buy |
+5,007
| New | +$833K | 0.01% | 861 |
|